Discovery and mechanism studies of a novel ATG4B inhibitor Ebselen by drug repurposing and its anti-colorectal cancer effects in mice.

MLA

Xie, Huazhong, et al. “Discovery and Mechanism Studies of a Novel ATG4B Inhibitor Ebselen by Drug Repurposing and Its Anti-Colorectal Cancer Effects in Mice.” Cell & Bioscience, vol. 12, no. 1, Dec. 2022, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s13578-022-00944-x.

APA

Xie, H., Qiang, P., Wang, Y., Xia, F., Liu, P., & Li, M. (2022). Discovery and mechanism studies of a novel ATG4B inhibitor Ebselen by drug repurposing and its anti-colorectal cancer effects in mice. Cell & Bioscience, 12(1), 1–17. https://doi.org/10.1186/s13578-022-00944-x

Chicago

Xie, Huazhong, Pengfei Qiang, Yao Wang, Fan Xia, Peiqing Liu, and Min Li. 2022. “Discovery and Mechanism Studies of a Novel ATG4B Inhibitor Ebselen by Drug Repurposing and Its Anti-Colorectal Cancer Effects in Mice.” Cell & Bioscience 12 (1): 1–17. doi:10.1186/s13578-022-00944-x.